Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior docetaxel – results from the phase II RAMIRIS Study of the German Gastric Cancer Study Group at AIO
Sylvie Lorenzen, Peter C Thuss-Patience, Claudia Pauligk, Eray Goekkurt, Thomas Jens Ettrich, Florian Lordick and 8 more
- Rank
- 42 of 1,164
- Percentile
- top 3.7%
- Where
- European Journal of Cancer, 2022
- Citations
- 58
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.